That Nonprofit Generic Firm Has A Name, $100 Million, And A CEO Who Will Work For Free

The not-for-profit generic drug firm that aims to prevent drug shortages and cut prices for patients now has a name—and a boss.

The effort will be called Civica Rx, and it will be run by chief executive Martin VanTrieste, the former chief quality officer for Amgen. VanTrieste, who in a prepared statement called the effort “a public asset,” has agreed to work without compensation.